Sustainability of measles, rubella, and congenital rubella syndrome (CRS) elimination in the United States, January 2022 - June 2024

Vaccine. 2025 Feb 6:46:126681. doi: 10.1016/j.vaccine.2024.126681. Epub 2025 Jan 1.

Authors

Alan R Hinman¹, Emily Banerjee², Noel T Brewer², Elisabeth S Hayes², David Kimberlin², Walter A Orenstein², Michele Roberts², Jane R Zucker²

Affiliations

¹ National Sustainability Committee for the Elimination of Measles, Rubella, and Congenital Rubella Syndrome (NSC), United States of America. Electronic address: [email protected].
² National Sustainability Committee for the Elimination of Measles, Rubella, and Congenital Rubella Syndrome (NSC), United States of America.

PMID: 39743458
DOI: 10.1016/j.vaccine.2024.126681

No abstract available

Keywords: Congenital rubella syndrome; Elimination; Measles; Rubella; Vaccination.